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126Analysis of 30-day readmission after aortoiliac and
infrainguinal revascularization using the American
College of Surgeons National Surgical Quality
Improvement Program data set
Daniel L. Davenport, PhD,a Brittany A. Zwischenberger, MD,b and Eleftherios S. Xenos, MD, PhD,a
Lexington, Ky
Objective: This study analyzed 30-day hospital readmissions after aortoiliac (AI) and infrainguinal (II) revascularization to
further characterize readmissions and to identify modiﬁable targets for reducing readmission rates.
Methods: We performed a retrospective analysis of the large, multicenter, prospectively collected American College of
Surgeons National Surgical Quality Improvement Program data set from 2011. Readmissions were categorized as
planned or unplanned and related or unrelated to the index procedure. The primary end point was unplanned read-
missions for open and endovascular AI and II procedures. Multivariable logistic regression was performed to determine
independent demographic and preoperative clinical and intraoperative risk factors for unplanned readmissions related to
the procedure.
Results: A total of 8414 patients were discharged after AI or II revascularization with a 30-day readmission rate of 16.5%.
Ninety percent of all readmissions were unplanned and 54% were unplanned and related to the index procedure. Reasons
for unplanned readmissions related to the procedure were infection (43.1%), diabetic/ischemic wound complications
(16.5%), graft complications (13.6%), cardiac events (3.6%), neurologic events (2.9%), and deep venous thrombosis/
pulmonary embolism (2.4%). Procedures were performed in the minority of all readmissions (7.7%) and included vascular
intervention (28.7%), amputation (24%), débridement (14%), and incision and drainage (10%). The rate of related
readmission for open revascularizations (10.9%) was double the rate for endovascular revascularizations (4.7%). Multi-
variate analysis identiﬁed several independent risk factors associated with unplanned readmissions related to the proce-
dure: open procedure (odds ratio [OR], 1.53; P[ .43), operative time of more than 260 minutes (OR, 1.66; P < .002),
blood transfusion (OR, 1.24; P[ .021), body mass index 30 to 35 (OR, 1.56; P < .001), and preoperative open wound/
infection (OR, 1.23; P [ .12). Interestingly, length of hospital stay and age were not independent predictors of
unplanned readmissions related to the procedure.
Conclusions: AI and II revascularization procedures result in readmission of 16.5% of patients. The most frequent reason
for readmission was surgical site infection. Interventions focused on wound care management and avoidance of infectious
complications could help reduce readmission rates. (J Vasc Surg 2014;60:1266-74.)Hospital readmissions are targeted as a signiﬁcant
source of increased costs of health care and especially
Medicare spending.1 Under the Centers for Medicare and
Medicaid Services Hospital Readmissions Reduction
Program, two thirds of U.S. hospitals are at risk for penaliza-
tion of 1% of their Medicare reimbursement if they experi-
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6infarction, heart failure, and pneumonia. The penalization
risk is to be increased to 3% of Medicare reimbursements
by ﬁscal year 2015.2 More important for vascular surgeons,
the Centers for Medicare and Medicaid Services has
proposed an expanded readmission measure beginning in
2015, “hospital-wide all-cause unplanned readmission.”3
This will include readmission after vascular surgery.
One of the ﬁrst studies to characterize hospital readmis-
sions with use of Medicare claims was by Jencks et al.4 This
study found that the overall 30-day readmission rate after a
surgical procedure was 15.6% and that the highest rate of
postsurgery readmission occurred after vascular surgery
(24%). A single-institution, prospectively collected database
reported 30-day readmission after discharge from the
vascular surgery service as 12%, with patients undergoing
lower extremity revascularization more likely to be readmit-
ted.5 Readmission rates for patients undergoing lower
extremity revascularization are reported between 15% and
26%.6-8 In comparison, abdominal aortic aneurysm repairs
were estimated to have a hospital readmission rate of 21%.9
According to the claims study of Jencks et al,4 the most
frequent reasons for readmission after a vascular procedure
Fig 1. Readmission classiﬁcation in the American College of Surgeons National Surgical Quality Improvement
Program (ACS NSQIP) protocol.
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Volume 60, Number 5 Davenport et al 1267were “other vascular surgery,” “amputation,” “heart fail-
ure,” and “other circulatory problems.” Subsequent studies
have attempted to differentiate planned vs unplanned read-
missions and to better characterize reasons for readmission.
Starting January 1, 2011, the American College of Sur-
geons National Surgical Quality Improvement Program
(ACS NSQIP) began capturing data on readmission within
30 days of major surgical procedures at more than 300 hos-
pitals. The protocol had data coordinators review the med-
ical record, assign a reason for the readmission, and
categorize the readmissions as planned vs unplanned. Un-
planned readmissions were further categorized as related
or not to the index procedure. This makes the ACS NSQIP
database one of the largest data sets available of non-
Medicare patient readmissions after surgery, with perhaps
greater clinical discrimination of events.
This study used the 2011 data set to analyze 30-day
hospital readmissions after aortoiliac (AI) and infrainguinal
(II) revascularization to communicate a broader national
benchmark for these procedures. It takes advantage of the
related and unrelated designation built into the ACSNSQIP
protocol to identify perioperative risks and reasons for
readmission that are potentially modiﬁable by the surgeon.
METHODS
This study is a retrospective review of the ACS NSQIP
data set from calendar year 2011. The University of Ken-
tucky Institutional ReviewBoard classiﬁed this blinded data-
base study as nonhuman subjects research andwaived further
review. The ACS NSQIP is a prospective, systematic study
of adult patients undergoing major surgical procedures atmore than 300 hospitals for the purposes of quality assess-
ment and improvement.1-4Data coordinators at participating
hospitals collected more than 35 preoperative demographic
and clinical characteristics, intraoperative processes of care,
and 22 uniformly deﬁned postoperative adverse occurrences
(including death) up to 30 days after the operation.
Traumatic admissions are excluded, as are cases performed
within 30 days of another case. This eliminates early redone
procedures from the sample.
We selected AI and II revascularization procedures
from the data set by matching the primary procedure
Current Procedural Terminology code to those listed in
the Supplementary Table. We then examined all secondary
codes to further group the operation as AI, II, or a combi-
nation of the two and as endovascular, open, or having
both endovascular and open procedures. There is no infor-
mation in the data set on whether the operation is a
“redo,” so cases were unable to be classiﬁed as such.
Return to the operating room and readmission up to
30 days after the operation (not discharge) to any hospital
were also collected. By protocol, readmissions were catego-
rized by the data coordinator as planned or unplanned, with
unplanned readmissions further categorized as related or un-
related to the index procedure (Fig 1). Unplanned readmis-
sions were the default category unless the readmission was
known at the time of the index procedure or a direct result
of the index procedure pathology, in which case it was
planned. Similarly, for unplanned readmissions, the default
categorization was related to the index procedure unless suf-
ﬁcient documentation existed to clearly categorize the read-
mission as unrelated in the data coordinator’s assessment.
Table I. The 30-day postoperative readmission rates after open or endovascular aortoiliac (AI) or infrainguinal (II)
revascularization
Index procedure AI, % II, %
Combined
AI and II, % P value Endovascular, % Open, %
Combined
endovascular
and open, % P value All, %
No. of patients surviving
to discharge <30 days after
operation
1685 6261 468 2868 5256 290 8414
Any 30-day readmission 12.9 17.5 15.2 <.001 14.5 17.6 15.5 .002 16.5
Readmission type .001 <.001
Planned 1.3 1.6 0.9 2.1 1.2 0.7 1.5
Unplanned and unrelated
to index procedure
5.1 6.5 5.8 7.7 5.5 3.8 6.2
Unplanned and related
to index procedure
6.5 9.4 8.5 4.7 10.9 11.0 8.8
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tation (including laboratory reports and pathology results)
associated with the readmission and used their judgment in
classifying readmissions as unrelated. The reason for the read-
mission was recorded by the data coordinator, who chose be-
tween a list of speciﬁc NSQIP complications or entered the
International Classiﬁcation of Diseases, Ninth Revision
(ICD-9) code from the readmission. Postoperative days to
readmission and reoperation were also recorded. We calcu-
lated in-hospital reoperations (any codes) and a subset of
in-hospital revisions with Current Procedural Terminology
codes 35700 to 35907.
Rates of unplanned readmissions related and unrelated
to the procedure were calculated by procedure groups. The
investigators aggregated the reasons for readmission (ACS
NSQIP complications and ICD-9 codes) into groups on
the basis of clinical judgment. Reason groups were then
tabulated by readmission type.
Preoperative and perioperative characteristics were
compared in the related and unrelated unplanned readmis-
sion groups vs patients not readmitted. Mann-Whitney
U test, t-test, c2 test, or Fisher exact test was used as appro-
priate to identify univariate risk factors. Given the multiple
comparisons, signiﬁcance was set at P < .005 to reduce the
chance of false-positive ﬁndings (type I error).
Two forward multivariable logistic regressions of related
and unrelated readmissions were performed considering all
the ACS NSQIP preoperative risk factors (P for entry < .05,
for exit > .10). Intraoperative variables were similarly added
into the model along with the ﬁxed preoperative variables.
All statistical analyses were performed with SPSS version 21
statistical software (IBM Corp, Armonk, NY).
RESULTS
A total of 8494 patients in the database had undergone
AI or II revascularization with recorded readmission status.
Patients had a mean age of 67.6 years (standard
deviation 6 11.6) and were 61.4% male. Of these, 115
(1.4%) died in-hospital and 80 (0.9%) remained
in-hospital at 30 days, leaving 8414 patients eligible for30-day readmission analysis. The overall 30-day readmission
rate was 16.5%, of which planned readmissions were 1.5%,
unplanned related readmissions were 8.8%, and unplanned
unrelated readmissionswere 6.2%.Rates are stratiﬁedbypro-
cedure group in Table I and Fig 2.
Reasons for readmissions by type are shown in
Table II. For related readmissions, the top four reasons
totaling more than 73% of related readmissions were surgi-
cal site infection (35.8%), graft complications (13.8%),
other infection and sepsis (12.8%), and diabetic/ischemic
wound complications (11.1%). In contrast, for unrelated
readmissions, the top reasons were vascular disease
(16.7%), cardiac (12.2%), gastrointestinal (10.9%), other
infection/sepsis (9.6%), and diabetic/ischemic wound
complication (8.4%), totaling 60% of unrelated readmis-
sions. Procedures were performed in the minority of all
readmissions (7.7%; Table III) and included vascular inter-
vention such as graft exploration and revision, thromboem-
bolectomy, and open or endovascular revascularization
(30%), major amputation (12%), foot/toe amputation
(10%), and débridement and incision and drainage (24%).
Patient preoperative characteristics that were signiﬁ-
cantly different in the readmission groups relative to the
patients not readmitted (P < .005) are shown in
Table IV stratiﬁed by risk factors that predicted both
related and unrelated readmissions, related readmissions
only, and unrelated readmissions only. Univariate preop-
erative risk factors for both related and unrelated readmis-
sions included transfer from other health care facility,
American Society of Anesthesiologists physical status clas-
siﬁcation, serum albumin (linear continuous), dyspnea,
preoperative open wound (including diabetic or ischemic
wounds), preoperative systemic inﬂammatory response
syndrome or sepsis, alkaline phosphatase >125 U/L,
hematocrit <38%, and serum glutamic oxaloacetic trans-
aminase >40 U/L.
Factors predictive of unrelated readmission only
included age, functional status, international normalized
ratio, diabetes, congestive heart failure, acute renal failure
or dialysis, preoperative transfusion >4 U packed red
Fig 2. The 30-day readmission rates after aortoiliac (AI) and infrainguinal (II) revascularization. endo, Endovascular.
Table II. Reasons for unplanned readmissions after
aortoiliac (AI) or infrainguinal (II) revascularization
Related to
procedure, %
Unrelated to
procedure, %
No. of patients 740 522
Surgical site infection/
dehiscence
35.8 1.9
Graft complication 13.8 2.1
Other infection/sepsis 12.8 9.6
Diabetic/ischemic wound
complication
11.1 8.4
Vascular disease 10.8 16.7
Cardiac 3.6 12.2
Neurologic/CVA/pain 3.0 6.7
DVT/PE 2.4 0.6
Renal 1.5 5.9
Pulmonary 1.5 6.1
Gastrointestinal 1.1 10.9
Heme 0.7 1.7
Failure to thrive 0.3 2.1
Endocrine 0.1 4.8
Musculoskeletal 0.1 1.7
Other/unclassiﬁed 1.4 8.4
CVA, Cerebrovascular accident; DVT, deep venous thrombosis;
PE, pulmonary embolism.
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>40 mg/dL. Conversely, obesity and elevated bilirubin
were signiﬁcantly higher in the related readmission group
but not in the unrelated readmission group. Elevated
bilirubin was a risk factor in both the AI and II cohorts.
Preoperative patient characteristics that were not signiﬁ-
cantly different in either readmission group included
gender, current smoker, history of severe chronic obstruc-
tive pulmonary disease (COPD), treated hypertension,
disseminated cancer or recent weight loss, steroid use,
bleeding disorder (including undocumented discontinu-
ance of blood thinners), platelets below 150 or above
400, elevated sodium, and reduced white blood cell count.
Perioperative characteristics that were signiﬁcantly
higher (P < .005) in either of the readmission groups
compared with patients not readmitted are shown in
Table V. Overall, patients undergoing II revascularization
were more likely to be readmitted than were patients
undergoingAI intervention. Patients undergoing II revascu-
larization had a signiﬁcantly higher rate than AI patients
of unplanned readmission for surgical site infection/
dehiscence (3.6% vs 2.2%; P ¼ .003) and a nonsigniﬁ-
cantly higher rate of unplanned readmission for sepsis/
other infection (1.9% vs 1.1%), diabetic/ishemic wound
complication (1.6% vs 1.0%), and graft failure (1.5% vs
0.9%). Open procedures were linked to a higher risk for
readmission compared with endovascular interventions.
Emergent cases did not present increased readmission
risk. Any return to the operating room during hospitaliza-
tion resulted in higher risk for related readmission, as did
in-hospital graft revision. Counterintuitively, longer
length of stay was linked to increased readmission.
Longer operations and perioperative transfusion were
risk factors for readmission, as was discharge to a rehabil-
itation or skilled nursing facility.With multivariable adjustment, 16 preoperative and
perioperative factors remained independent predictors of
related readmissions (Table VI). Factors already identiﬁed
in the univariate analysis included the following: open pro-
cedure; in-hospital revision, operative time of more than
260 minutes; blood transfusion; obesity classes I, II, and
III; and preoperative open wound. Factors that were not
identiﬁed by univariate analysis but that became signiﬁcant
in the presence of the other variables were female gender
and COPD. The regression Hosmer-Lemeshow statistic
Table III. Procedures performed during readmission
Index procedure
AI endovascular,
No. (%)
AI open,
No. (%)
II endovascular,
No. (%)
II open,
No. (%)
All,
No. (%)
No. of patients surviving to discharge
<30 days after operation
854 1023 2035 4502 8414
Any 30-day readmission 107 (12.5) 141 (13.8) 313 (15.4) 826 (18.3) 1387 (16.5)
Operative readmission 38 (4.4) 53 (5.2) 128 (6.3) 302 (6.7) 521 (6.2)
Débridement 3 9 7 60 79
Incision and drainage 0 12 5 46 63
Graft excision/exploration/
revision/repair
1 11 5 47 64
Amputation, foot/toe 3 1 26 24 54
Amputation, major 3 2 18 38 61
Bypass 7 4 15 13 39
Endovascular revascularization 7 2 13 3 25
Embolectomy/thrombectomy 2 2 2 11 17
Thromboendarterectomy 2 0 6 4 12
Other 10 10 31 56 107
AI, Aortoiliac; II, infrainguinal.
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indicating good calibration.10
DISCUSSION
These results from a large multicenter study with pro-
spective review of readmission provide benchmarks for
readmission after open and endovascular AI and II revascu-
larization. Our analysis is a starting point toward the devel-
opment of strategies that can be tailored to the
contributing clinical risk factors and, unlike prior studies,
includes endoluminal interventions. It has been shown
that preventing complications tracked in the ACS NSQIP
could reduce readmissions and lead to an estimated Medi-
care savings of $620 million/year.11
The ACS NSQIP database provides validated read-
mission data and represents one of the largest data sets
available of non-Medicare patient readmissions after sur-
gery.12 Major advantages of the ACS NSQIP protocol
compared with claims-based studies are prospective review
of the readmission medical record, identiﬁcation of the
reason for readmission, and classiﬁcation of the readmission
as related or unrelated to the index procedure. The reasons
and risk factors for readmission were, as expected, different
between the two groups and may be of help in designing
interventions to reduce readmission rate. Jencks et al4 esti-
mated that approximately 10% of readmissions in their
study were planned; in view of the reimbursement implica-
tions, distinguishing between unplanned and planned 30-
day readmission would be important for vascular surgery
patients. Furthermore, 41% of the readmissions were unre-
lated to the index problem, highlighting the need for clear
deﬁnition of the metrics that can have signiﬁcant ﬁnancial
consequences for health care organizations.
This study found readmission rates lower than those
reported by McPhee et al,7 possibly because of the differ-
ence in timing. The ACS NSQIP deﬁnition is 30 days after
operation rather than the more commonly used 30 days
after discharge. Our data are also current and may reﬂect
changes in practice. Overall, II revascularization had higherreadmission than AI, and open procedures had more read-
mission than endovascular. Our ﬁndings are similar to the
rate of readmission of 16.4% after bypass graft as reported
by Gupta et al.13 Similarly, Jackson et al,5 in a single-
institution study, reported a rate of 14% of unplanned
30-day readmission after open lower extremity revasculari-
zation. Interestingly, in this study, 25% of readmissions
were planned. Our planned readmission rate was 1.5%;
this was in line with the 1.5% planned readmission rate re-
ported by Zhang et al.14
The main reason for related readmissions was surgical
site infection and dehiscence. Consequently, the most
frequently performed procedures during readmissions
were débridement and incision and drainage. The risk fac-
tors we identiﬁed include predictors of surgical site infec-
tion: American Society of Anesthesiologists class, obesity,
operative duration, blood transfusion, and open vs endo-
vascular approach. Operative approach and the use of
transfusion depend on the clinical presentation as well as
on surgical judgment and technique. Gibson et al15
recently reported that more than 50% of the patients diag-
nosed with a surgical site infection after an inpatient gen-
eral surgical procedure were readmitted. Greenblatt
et al16 reported that it confers 40% increased risk of surgical
site infection. Underscoring the importance of periopera-
tive management and operative technique is the recent
study from the Vascular Study Group of New England
Database, which found that perioperative blood transfusion
of three units or more increased the risk of surgical site
infection by threefold after lower extremity bypass as well
as the risk of graft thrombosis.17
After surgical site infection, graft complications were
the next most frequent reason for related readmission.
Graft revision procedures for thrombosis were performed
in 12% of the operative readmissions. Most of these were
in patients who had an open index procedure, and the ma-
jority occurred after II revascularizations. Almost 10%
of patients readmitted in the study by Jackson et al5
underwent intervention for graft thrombosis. Conversely,
Table IV. Index case preoperative characteristics for patients subsequently readmitted within 30 days of the procedure vs
patients not readmitted
Not
readmitted
Unplanned
unrelated readmission P value
Unplanned
relatedreadmission P value
No. of patients 7027 522 740
Univariate preoperative risk factors for both unrelated and related readmission
Transferred from <.001 <.001
Acute care hospital 3.2 4.8 4.6
Nursing home 2.7 6.5 5.3
Outside ED 2.3 2.7 2.7
ASA class vs 1-2 11.9 11.8 <.001 5.1 <.001
3 70.6 57.7 68.0
4-5 17.5 30.5 26.9
Mean serum albumin, g/dL (SD) 3.59 (.46) 3.38 (.55) <.001 3.52 (.50) .001
Preoperative open wound 27.8 51.0 <.001 36.2 <.001
Alkaline phosphatase >125 U/L 5.5 11.9 <.001 9.7 <.001
HCT <38% 49.0 66.5 <.001 56.8 <.001
SGOT >40 U/L 4.7 7.7 .004 7.6 .001
Dyspnea with moderate exertion 12.9 16.9 <.001 16.9 .004
Dyspnea at rest 1.2 2.9 1.8
Preoperative SIRS/sepsis 3.8 8.0 <.001 6.1 .004
Univariate preoperative risk factors for related readmissions only
BMI vs normal, 18.5-25 kg/m2 32.5 27.3 <.001
Underweight, <18.5 5.3 5.0
Overweight, 25.1-30 34.8 31.2
Obese I, 30.1-35 18.0 22.0
Obese II, 35.1-40 6.3 8.5
Obese III, >40 3.0 5.9
Bilirubin >1 mg/dL 2.7 4.7 .004
Univariate preoperative risk factors for unrelated readmissions only
Mean age, years (SD) 67.4 (11.6) 69.3 (11.9) <.001
Partial/full functional dependent 8.7 21.3 <.001
Mean INR (SD) 1.13 (.31) 1.18 (.35) <.001
Diabetes, insulin or medications 40.3 53.3 <.001
Congestive heart failure 2.1 7.7 <.001
Acute renal failure 1.0 3.3 <.001
On dialysis 5.2 18.2 <.001
Preoperative transfusion >4 U 1.9 4.6 <.001
BUN >40 mg/dL 5.7 12.6 <.001
Creatinine >1.2 mg/dL 28.1 45.4 <.001
Sodium <135 mmol/L 12.6 17.8 .001
WBCs >11,000/mm3 12.7 19.2 <.001
ASA, American Society of Anesthesiologists; BMI, body mass index; BUN, blood urea nitrogen; ED, emergency department; HCT, hematocrit; INR,
international normalized ratio; SD, standard deviation; SGOT, serum glutamic oxaloacetic transaminase; SIRS, systemic inﬂammatory response syndrome;
WBCs, white blood cells.
Data are presented as percentages unless otherwise indicated. Only signiﬁcant risk factors for related or unrelated readmissions are shown (P < .005).
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leg in 20% of readmitted patients. This may be related
to the fact that all their patients had critical ischemia.
Short-term bypass graft patency is dependent on technical
considerations but also on the type of the conduit. Great
saphenous vein offers the best 30-day patency (30-day
failure of 7.4%), followed by prosthetic (30-day failure
of 11%); composite grafts have a higher failure rate than
prosthetic grafts.18
Diabetic and ischemic wound complications as well as
other infections, including sepsis, were the next largest
group of related readmissions. Débridement was a
commonly performed procedure in readmitted patients
as stated before. A risk factor for related readmission was
a preoperative open wound, but diabetes was a risk factor
for unrelated but not related readmissions. Earlyrecognition could potentially help avoid a readmission
with aggressive outpatient wound management, home
health nursing, clinic visits, and antibiotics. It would be
especially important to identify patients who lack the abil-
ity to care for their wounds after discharge because of
inadequate education or support.19 Electronic transmis-
sion of wound photographs at different points in time
could also help with wound monitoring and early identi-
ﬁcation of wound complications.
Patient-dependent risk factors for unplanned readmis-
sions included obesity, open wound, COPD, and female
gender. Previous reports have identiﬁed chronic renal fail-
ure as a predictor of rehospitalization.5 In our study, age,
COPD, congestive heart failure, diabetes, functional
dependence, renal failure, and elevated creatinine concen-
tration were risk factors for unrelated readmission but not
Table V. Index case perioperative differences in patients subsequently readmitted within 30 days of the procedure (vs not
readmitted patients)
Not
readmitted
Unplanned
unrelated readmission P value
Unplanned
related readmission P value
No. of patients 7027 522 740
Infrainguinal procedure (vs aortoiliac) 76.8 83.2 <.001
Open procedure (vs endovascular) 64.9 57.5 .001 81.5 <.001
Elective surgery 71.7 58.8 <.001 60.7 <.001
Outpatient 15.4 5.4 <.001
Mean operative duration, minutes 6 SD 175 6 111 217 6 117 <.001
Perioperative transfusion 18.3 24.3 .001 30.8 <.001
Median LOS, days (IQR) 4 (1-8) 6 (2-11) <.001 6 (3-9.8) <.001
In-hospital return to OR 6.9 10.1 .002
In-hospital graft revision 1.1 3.1 <.001
Discharged to rehabilitation facility 7.2 10.3 <.001 9.7 <.001
Discharged to skilled nursing home 9.4 17.0 14.2
IQR, Interquartile range; LOS, length of stay; OR, operating room; SD, standard deviation.
Data are presented as percentages unless otherwise indicated.
Table VI. Independent predictors of unplanned 30-day readmission related to the procedure from the logistic regressionmodel
Step entered Variable ORa (95% CI) P value
1 ASA class vs 1-2
3 1.34 (0.93-1.92) .117
4-5 1.85 (1.25-2.73) .002
Unclassiﬁed 0.14 (0.05-0.41) <.001
2 BMI vs normal, 18.5-25 kg/m2
Underweight, <18.5 1.03 (0.71-1.50) .860
Overweight, 25.1-30 1.12 (0.92-1.37) .256
Obese I, 30.1-35 1.55 (1.24-1.93) <.001
Obese II, 35.1-40 1.68 (1.24-2.28) .001
Obese III, >40 2.44 (1.70-3.51) <.001
3 Alkaline phosphatase >125 U/L 1.52 (1.15-2.00) .003
4 Preoperative open wound 1.30 (1.10-1.54) .002
5 Patient transferred from other health care facility 1.30 (1.03-1.65) .028
6 Platelet count < 150,000/mm2 1.34 (1.06-1.69) .016
7 Females vs males 1.20 (1.03-1.41) .021
8 SGOT >40 U/L 1.39 (1.03-1.89) .021
9 History of severe COPD 1.24 (1.00-1.53) .046
10 Operative duration quintilevs <87 minutes
87-131 0.93 (0.68-1.28) .671
132-187 1.13 (0.82-1.55) .449
188-259 1.21 (0.88-1.66) .251
260þ 1.62 (1.17-2.24) .003
11 Open only vs endovascular only 1.44 (1.12-1.86) .005
Both open and endovascular 1.49 (0.92-2.43) .109
12 Transfused PRBCs within 72 hours of operation 1.29 (1.07-1.55) .008
13 Outpatient surgery 0.67 (0.46-0.98) .039
14 II only vs AI only 1.32 (1.06-1.65) .014
Both AI & II 1.20 (0.78-1.84) .412
15 Revision during index hospitalization 2.22 (1.36-3.62) .001
16 Urinary tract infection during index hospitalization 0.19 (0.05-0.79) .022
AI, Aortoiliac; ASA, American Society of Anesthesiologists; BMI, body mass index; CI, conﬁdence interval; COPD, chronic obstructive pulmonary disease; II,
infrainguinal; OR, odds ratio; PRBCs, plasma red blood cells; SGOT, serum glutamic oxaloacetic transaminase.
aIn this regression performed in two forward stages, the ORs and P values shown for the preoperative factors are those before inclusion of the perioperative factors.
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sions were vascular disease and cardiac and gastrointestinal
problems. Vascular surgery patients have substantial
comorbidities that contribute to unrelated readmission,
conﬁrming studies by others.5,6,20
There is conﬂicting information about the length of
stay and readmission. Kohlnhofer et al19 identiﬁed short
length of stay as predisposing to readmissions after generalsurgery procedures. In contrast, longer length of stay was a
risk factor for readmission in our study. Association
between longer length of stay and readmission has also
been reported after colorectal surgery21 and bariatric sur-
gery.22 We theorize that it is the increased acuity and
comorbidities driving increased length of stay that are
also driving increased readmission. We found similar results
related to discharge to skilled care. One might surmise that
JOURNAL OF VASCULAR SURGERY
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prevent readmission because these patients receive skilled
care to a varying degree. We actually found the opposite,
and it is again likely in our estimation that their higher acu-
ity and comorbidities requiring the skilled care are driving
the readmissions. Jannuzzi et al23 also reported that
discharge destination other than home was associated
with readmission.
Given the prevalence of unrelated readmissions in this
patient cohort (41% of unplanned readmissions) and the
number of clinical comorbid predictors of unrelated read-
missions only, the question is raised whether the Medicare
hospital-wide readmission measure will be adequately risk
adjusted. If not, hospitals could be unfairly ﬁnancially
penalized for frequent unrelated vascular surgery readmis-
sions under the new measure.
Planned procedures, which play an important role in
the treatment of critical limb ischemia, have been reported
at approximately 3% of readmissions.5,8 The ACS NSQIP
protocol requires that the follow-up procedure be known
at the time of the index procedure to be classiﬁed as
planned. Consequently, amputations after failed revascular-
ization are classiﬁed as unplanned and related as our list of
procedures shows. This might explain the fact that the 1.5%
planned rate of readmission in our cohort was lower than
the rates previously reported.8
Our study has limitations intrinsic to retrospective data-
base review, including the inability to assign causality and
known selection and treatment bias. Also, the ACS NSQIP
2011 data did not have clinical presentation data (ie, claudi-
cation vs critical limb ischemia). Categorization of readmis-
sion reasons for diabetic/ischemic wounds was challenging,
as was differentiation of surgical site wound complications
from diabetic/ischemic wound complications. However,
compared with other database analyses, the ACS NSQIP
presents some strengths as well: more than 300 hospitals
participate, the outcomes are observed after discharge by
patient contact, and the data coordinators review the med-
ical record in categorizing related vs unrelated readmission
and assigning reasons for readmission. Although there is
likely error in some of these assignments, they represent a
step forward in this area of assessing readmission.
CONCLUSIONS
The high rate of readmission after vascular surgeries,
along with possible future ﬁnancial penalization of hospitals,
necessitates research to guide resource allocation and to
form strategies to reduce them. Our results show that stra-
tegies to reduce surgical site infection and other infections,
to improve wound management, and to reduce early graft
failure have the potential to reduce readmissions related to
AI and II revascularization. We also show that comorbid
conditions are frequent in vascular surgery patients and are
predictive of high rates of unrelated readmission. Measures
of readmission will need to adequately reﬂect these risks.
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